• Stanislaw P Stawicki, Jill C Stoltzfus, Praveen Aggarwal, Sanjeev Bhoi, Shashi Bhatt, O P Kalra, Ashish Bhalla, Brian A Hoey, Sagar C Galwankar, Lorenzo Paladino, and Thomas J Papadimos.
• Department of Research and Innovation, Research Institute, Bethlehem, Pennsylvania ; Department of Research and Innovation, OPUS 12 Foundation Global, Columbus, USA.
• Int J Crit Illn Inj Sci. 2014 Jul 1; 4 (3): 200-8.

AbstractBiomarker science brings great promise to clinical medicine. This is especially true in the era of technology miniaturization, rapid dissemination of knowledge, and point-of-care (POC) implementation of novel diagnostics. Despite this tremendous progress, the journey from a candidate biomarker to a scientifically validated biomarker continues to be an arduous one. In addition to substantial financial resources, biomarker research requires considerable expertise and a multidisciplinary approach. Investigational designs must also be taken into account, with the randomized controlled trial remaining the "gold standard". The authors present a condensed overview of biomarker science and associated investigational methods, followed by specific examples from clinical areas where biomarker development and/or implementation resulted in tangible enhancements in patient care. This manuscript also serves as a call to arms for the establishment of a truly global, well-coordinated infrastructure dedicated to biomarker research and development, with focus on delivery of the latest discoveries directly to the patient via point-of-care technology.

3 keywords...

hide…